<DOC>
	<DOCNO>NCT02760121</DOCNO>
	<brief_summary>The purpose proposal compare physiological effect acetazolamide ( AZ ) methazolamide ( MZ ) control breathe hypoxic pulmonary vasoconstriction . The first objective ass effect AZ MZ control breathe normoxia hypoxia . To achieve ventilatory interaction oxygen carbon dioxide measure effect compare placebo , AZ , MZ condition . In addition , isocapnic poikilocapnic hypoxic ventilatory response hypercapnic ventilatory response measure drug . The second objective ass effect AZ MZ control pulmonary vasculature hypoxia . Pulmonary pressure cardiac output measure 60 minute poikilocapnic hypoxia .</brief_summary>
	<brief_title>AZ , MZ , Pulmonary System Response Hypoxia</brief_title>
	<detailed_description />
	<mesh_term>Hypertension , Pulmonary</mesh_term>
	<mesh_term>Altitude Sickness</mesh_term>
	<mesh_term>Acetazolamide</mesh_term>
	<mesh_term>Carbonic Anhydrase Inhibitors</mesh_term>
	<mesh_term>Methazolamide</mesh_term>
	<criteria>1840 year age regularly physically active male exsmokers pulmonary function &lt; 80 % predict contraindication carbonic anhydrase inhibitor ( eg . severe absolute glaucoma , adrenocortical insufficiency , hepatic insufficiency , renal insufficiency , sulfa allergy electrolyte imbalance hyperchloremic acidosis ) Obese ( BMI &gt; 30Kg/m2 ) diuretic medication use blood thinner use antiplatelet drug use .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Acetazolamide</keyword>
	<keyword>Methazolamide</keyword>
	<keyword>Control breathing</keyword>
	<keyword>Hypoxic pulmonary vasoconstriction</keyword>
</DOC>